243 related articles for article (PubMed ID: 17762629)
1. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
Schmidbauer J; Marberger M
Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
[TBL] [Abstract][Full Text] [Related]
2. Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer.
Sievert KD; Kruck S
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1055-63. PubMed ID: 19671025
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence cystoscopy: is it ready for use in routine clinical practice?
Spiess PE; Grossman HB
Curr Opin Urol; 2006 Sep; 16(5):372-6. PubMed ID: 16905985
[TBL] [Abstract][Full Text] [Related]
4. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
Witjes JA; Douglass J
Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
[TBL] [Abstract][Full Text] [Related]
5. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
6. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
7. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305).
Mostafid H; Bunce C;
BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121
[No Abstract] [Full Text] [Related]
8. [Fluorescence guided endoscopy: improvement in the management of bladder cancer].
Uffer M; Jichlinski P
Rev Med Suisse; 2010 Dec; 6(274):2352-4. PubMed ID: 21290867
[TBL] [Abstract][Full Text] [Related]
9. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW
BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804
[TBL] [Abstract][Full Text] [Related]
10. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
11. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
12. [Fluorescence diagnosis and photodynamic therapy in urology].
Stepp H; Waidelich R
Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533
[TBL] [Abstract][Full Text] [Related]
13. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
14. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
15. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
D'Hallewin MA; De Witte PA; Waelkens E; Merlevede W; Baert L
J Urol; 2000 Aug; 164(2):349-51. PubMed ID: 10893582
[TBL] [Abstract][Full Text] [Related]
17. [ALA fluorescent diagnosis of bladder cancer].
Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
Urologiia; 2000; (5):48-50. PubMed ID: 11392226
[TBL] [Abstract][Full Text] [Related]
18. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
Loidl W; Schmidbauer J; Susani M; Marberger M
Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
[TBL] [Abstract][Full Text] [Related]
19. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
20. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Stenzl A; Penkoff H; Dajc-Sommerer E; Zumbraegel A; Hoeltl L; Scholz M; Riedl C; Bugelnig J; Hobisch A; Burger M; Mikuz G; Pichlmeier U
Cancer; 2011 Mar; 117(5):938-47. PubMed ID: 21351082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]